Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7295 USD | -4.01% | +16.29% | -47.89% |
Apr. 09 | Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT | CI |
Apr. 08 | Declaration of Voting Results by Seres Therapeutics | CI |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.